{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:02:25Z","timestamp":1792796545501,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001626","name":"Public Health Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001626","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008303","name":"Department for Employment and Learning, Northern Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008303","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000873","name":"Queen's University Belfast","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.chest.2021.11.006","type":"journal-article","created":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T23:46:56Z","timestamp":1636847216000},"page":"1275-1284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Aspirin as a Treatment for ARDS"],"prefix":"10.1016","volume":"161","author":[{"given":"Philip","family":"Toner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"McNamee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Trinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejina","family":"Verghis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia M.","family":"O\u2019Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.chest.2021.11.006_bib1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and\u00a0mortality for patients with acute\u00a0respiratory distress syndrome\u00a0in\u00a0intensive care units in 50\u00a0countries","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.chest.2021.11.006_bib2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1164\/rccm.200505-693OC","article-title":"Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome","volume":"174","author":"Cheung","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.11.006_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1741-7015-11-166","article-title":"Pharmacological treatments in ARDS: a state-of-the-art update","volume":"11","author":"Boyle","year":"2013","journal-title":"BMC Med"},{"issue":"374","key":"10.1016\/j.chest.2021.11.006_bib4","first-page":"1","article-title":"Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome","volume":"19","author":"Toner","year":"2015","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.chest.2021.11.006_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1378\/chest.14-1246","article-title":"Platelet count mediates the contribution of a genetic variant in LRRC16A to ARDS risk","volume":"147","author":"Wei","year":"2015","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2021.11.006_bib6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1378\/chest.96.5.1125","article-title":"Platelet- specific \u03b1-granule proteins and thrombospondin in bronchoalveolar lavage in the adult respiratory distress syndrome","volume":"96","author":"Idell","year":"1989","journal-title":"Chest"},{"key":"10.1016\/j.chest.2021.11.006_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ajh.2830250404","article-title":"Platelet function in acute respiratory failure","volume":"25","author":"Carvalho","year":"1987","journal-title":"Am J Hematol"},{"issue":"7648","key":"10.1016\/j.chest.2021.11.006_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature21706","article-title":"The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors","volume":"544","author":"Lefran\u00e7ais","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.chest.2021.11.006_bib9","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/CCM.0b013e31819ceb71","article-title":"Platelets support pulmonary recruitment of neutrophils in abdominal sepsis","volume":"37","author":"Asaduzzaman","year":"2009","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2021.11.006_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/rccm.200810-1601OC","article-title":"15-Epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury","volume":"180","author":"El Kebir","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.11.006_bib11","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1172\/JCI29499","article-title":"Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation","volume":"116","author":"Zarbock","year":"2006","journal-title":"J\u00a0Clin Invest"},{"issue":"17","key":"10.1016\/j.chest.2021.11.006_bib12","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1182\/blood-2014-03-562876","article-title":"Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice","volume":"124","author":"Ortiz-Mu\u00f1oz","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.chest.2021.11.006_bib13","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.ajem.2018.05.017","article-title":"The effect of aspirin in preventing the acute respiratory distress syndrome\/acute lung injury: a meta-analysis","volume":"36","author":"Yu","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"4","key":"10.1016\/j.chest.2021.11.006_bib14","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4103\/0971-9784.191576","article-title":"Effect of antiplatelet therapy on mortality and acute lung injury in critically ill patients: a systematic review and meta-analysis","volume":"19","author":"Mohananey","year":"2016","journal-title":"Ann Card Anaesth"},{"issue":"1","key":"10.1016\/j.chest.2021.11.006_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13054-015-0846-4","article-title":"Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis","volume":"19","author":"Boyle","year":"2015","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.chest.2021.11.006_bib16","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/CCM.0b013e3182120992","article-title":"Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury\/acute respiratory distress syndrome","volume":"39","author":"O\u2019Neal","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.chest.2021.11.006_bib17","doi-asserted-by":"crossref","first-page":"720254","DOI":"10.1155\/2012\/720254","article-title":"Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients?","volume":"2012","author":"L\u00f6sche","year":"2012","journal-title":"Thrombosis"},{"issue":"11","key":"10.1016\/j.chest.2021.11.006_bib18","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/CCM.0000000000002654","article-title":"Quantifying the effects of prior acetyl-salicylic acid on sepsis- related deaths: an individual patient data meta-analysis using propensity matching","volume":"45","author":"Trauer","year":"2017","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.chest.2021.11.006_bib19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/thoraxjnl-2016-208571","article-title":"Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS","volume":"72","author":"Hamid","year":"2017","journal-title":"Thorax"},{"issue":"22","key":"10.1016\/j.chest.2021.11.006_bib20","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1001\/jama.2016.6330","article-title":"Effect of aspirin on development of ARDS in at-risk patients presenting to the emergency department: the LIPS-A randomized clinical trial","volume":"315","author":"Kor","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.chest.2021.11.006_bib21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.chest.2021.11.006_bib39","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1164\/rccm.201712-2530OC","article-title":"Early intravascular events are associated with development of acute respiratory distress syndrome: a sub-study of the LIPS-A clinical study","volume":"197","author":"Abdulnour","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.11.006_bib22","first-page":"1","article-title":"Aspirin as a treatment for acute respiratory distress syndrome: a multi-centre, randomised, study protocol","volume":"1","author":"Toner","year":"2018","journal-title":"Crit Care Horizons"},{"key":"10.1016\/j.chest.2021.11.006_bib23","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"23","key":"10.1016\/j.chest.2021.11.006_bib24","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.chest.2021.11.006_bib25","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S2213-2600(17)30171-6","article-title":"Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo controlled trial","volume":"5","author":"McAuley","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2021.11.006_bib26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1164\/rccm.201003-0423OC","article-title":"A\u00a0randomized clinical trial of hydroxymethylglutaryl-coenzyme A reductase inhibition for acute lung injury (the HARP study)","volume":"183","author":"Craig","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"18","key":"10.1016\/j.chest.2021.11.006_bib27","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1403285","article-title":"Simvastatin in the acute respiratory distress syndrome","volume":"371","author":"McAuley","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.chest.2021.11.006_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232720","article-title":"Prediction of outcome in patients with ARDS: a prospective cohort study comparing ARDS-definitions and other ARDS-associated parameters, ratios and scores at intubation and over time","volume":"15","author":"Huber","year":"2020","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.chest.2021.11.006_bib29","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa050333","article-title":"Incidence and outcomes of acute lung injury","volume":"353","author":"Rubenfeld","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.chest.2021.11.006_bib30","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1136\/thx.2007.093658","article-title":"Predictors of mortality in acute lung injury during the era of lung protective ventilation","volume":"63","author":"Seeley","year":"2008","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.chest.2021.11.006_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/cc3977","article-title":"PAC-Man: game over for the pulmonary artery catheter?","volume":"10","author":"Reade","year":"2006","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.chest.2021.11.006_bib32","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1378\/chest.11-1396","article-title":"Introduction to drug pharmacokinetics in the critically ill patient","volume":"141","author":"Smith","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.chest.2021.11.006_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2014.07.006","article-title":"The effect of pathophysiology on pharmacokinetics in the critically ill patient: concepts appraised by the example of antimicrobial agents","volume":"77","author":"Blot","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"10.1016\/j.chest.2021.11.006_bib34","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/eci.12771","article-title":"Acetylsalicylic acid in critically ill patients: a cross-sectional and a randomized trial","volume":"47","author":"Schoergenhofer","year":"2017","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.chest.2021.11.006_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40261-013-0145-2","article-title":"Pharmacodynamics and pharmacokinetics of a novel, low-dose, soft-gel capsule of acetylsalicylic acid in comparison with an oral solution after single-dose administration to healthy volunteers: a phase I, two-way crossover study","volume":"34","author":"Loprete","year":"2014","journal-title":"Clin Drug Investig"},{"issue":"4","key":"10.1016\/j.chest.2021.11.006_bib36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5811\/westjem.2011.4.2222","article-title":"Comparison of three aspirin formulations in human volunteers","volume":"12","author":"Nordt","year":"2011","journal-title":"West J Emerg Med"},{"issue":"suppl 4","key":"10.1016\/j.chest.2021.11.006_bib37","first-page":"171","article-title":"[Clinical pharmacology of acetylsalicylic acid] [article in German]","volume":"81","author":"Schr\u00f6der","year":"1992","journal-title":"Z\u00a0Kardiol"},{"issue":"1","key":"10.1016\/j.chest.2021.11.006_bib38","first-page":"1","article-title":"Latent class analysis of ARDS subphenotypes: analysis of data from two randomised control trials","volume":"23","author":"Calfee","year":"2014","journal-title":"Lancet Respir Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221042896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221042896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T23:02:55Z","timestamp":1762124575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369221042896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0012369221042896"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2021.11.006","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin as a Treatment for ARDS","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Inc. under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}